Compare PRA & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRA | ATRC |
|---|---|---|
| Founded | 1976 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2000 | 2005 |
| Metric | PRA | ATRC |
|---|---|---|
| Price | $24.61 | $28.91 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $25.00 | ★ $51.17 |
| AVG Volume (30 Days) | ★ 822.2K | 791.1K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $1,098,028,000.00 | $201,630,000.00 |
| Revenue This Year | N/A | $15.27 |
| Revenue Next Year | N/A | $12.21 |
| P/E Ratio | $154.03 | ★ N/A |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $22.79 | $25.52 |
| 52 Week High | $24.85 | $43.18 |
| Indicator | PRA | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 49.87 | 54.93 |
| Support Level | $24.54 | $28.41 |
| Resistance Level | $24.64 | $30.75 |
| Average True Range (ATR) | 0.11 | 1.37 |
| MACD | -0.01 | 0.22 |
| Stochastic Oscillator | 42.37 | 85.40 |
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in four segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.